Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study

BACKGROUND: Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) emerged as important fungal complications in patients with COVID-19-associated severe acute respiratory failure (ARF). Whether mould active antifungal prophylaxis (MAFP) can prevent CAPA remains elusive so far. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatzl, Stefan, Reisinger, Alexander C., Posch, Florian, Prattes, Juergen, Stradner, Martin, Pilz, Stefan, Eller, Philipp, Schoerghuber, Michael, Toller, Wolfgang, Gorkiewicz, Gregor, Metnitz, Philipp, Rief, Martin, Prüller, Florian, Rosenkranz, Alexander R., Valentin, Thomas, Krause, Robert, Hoenigl, Martin, Schilcher, Gernot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441945/
https://www.ncbi.nlm.nih.gov/pubmed/34526087
http://dx.doi.org/10.1186/s13054-021-03753-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441945/
https://www.ncbi.nlm.nih.gov/pubmed/34526087
http://dx.doi.org/10.1186/s13054-021-03753-9

Ejemplares similares